Keywords: cv, ranolazine, shortens, qt, interval, usa-based, therapeutics

CV's ranolazine shortens QT interval

Article | 01 September 2008

Print This

USA-based CV Therapeutics says that a study has been published in the latest edition of Journal of Cardiovascular Electrophysiology showing ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in